Journal
NEUROPSYCHOPHARMACOLOGY
Volume 26, Issue 6, Pages 744-755Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S0893-133X(01)00413-4
Keywords
delta opioid receptor; depression; forced swim assay; SNC80; (+)BW373U86
Categories
Funding
- NIDA NIH HHS [DA07267, DA00254] Funding Source: Medline
- NIGMS NIH HHS [GM07767] Funding Source: Medline
Ask authors/readers for more resources
The present study examined the effect of opioid receptor agonists in the rat forced swim assay. The delta-opioid receptor agonists SNC80 ((+)-4-[(aR)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N- diethylbenzamide) and (+)BW373U86 ((+)-[1(S*),2alpha,5beta]-4-[[2,5-dimethyl-4-(2-propenyl)-1-piperazinyl] (3-hydroxyphenyl)methyl]-N,N-diethyl-benzamide dihydrochloride) produced a decrease in immobility indicating an antidepressant-like effect. At antinociceptive doses, neither the kappa-opioid selective agonist C1977 (5R-(5alpha,7alpha,8beta)-N-methyl-N-[7-(1-pyrrolidinyl-1- oxaspiro[4,5]dec-8-yl]-4-benzofuranacetamide) showed a change in immobility that was identifiable by dose, nor were changes in immobility seen with morphine. A delta-opioid mechanism of action in the forced swim assail was likely since naltrindole prevented the effects of both delta-agonists. When compared to desipramine and fluoxetine, SNC80 was more active with a single dose whereas both desipramine and fluoxetine produced greater effects with subchronic dosing (3 doses). All three compounds were active when administered before the initial swim exposure. SNC80 was, however, more effective following a single dose than by subchronic administration demonstrating both a fast onset of activity and potential tolerance, Thus, delta-agonists differ from typical antidepressants in the forced swim assay. (C) 2002 American College of Neuropsychopharmacology. Published by Elsevier Science Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available